These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2729304)

  • 1. Laboratory tests recommended by pharmacists in a skilled-nursing facility.
    Longe RL
    Am J Hosp Pharm; 1989 May; 46(5):970-2. PubMed ID: 2729304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine laboratory tests: helpful or just costly?
    Cooper JW
    Nurs Homes Sr Citiz Care; 1988 Dec; 37(6):8-10. PubMed ID: 10291502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The health care cost of drug-related morbidity and mortality in nursing facilities.
    Bootman JL; Harrison DL; Cox E
    Arch Intern Med; 1997 Oct; 157(18):2089-96. PubMed ID: 9382665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug regimen review in skilled nursing facilities by consulting clinical pharmacists.
    Witte KW; Leeds NH; Pathak DS; Campagna KD; West DP; Spunt AL
    Am J Hosp Pharm; 1980 Jun; 37(6):820-4. PubMed ID: 7395876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A consultant pharmacist's use of a portable microcomputer at several skilled nursing facilities.
    Kohll DG; Young WW
    Hosp Pharm; 1986 Oct; 21(10):943-6, 953-4. PubMed ID: 10278984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical pharmacist in a multidisciplinary team in a paediatric department].
    Kjeldby C; Bjerre A; Refsum N
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1746-9. PubMed ID: 19756055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family practice physicians' perceptions of the usefulness of drug therapy recommendations from clinical pharmacists.
    Haxby DG; Weart CW; Goodman BW
    Am J Hosp Pharm; 1988 Apr; 45(4):824-7. PubMed ID: 3376965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the need for pharmacist-conducted drug regimen reviews in skilled nursing and intermediate care facilities.
    McGhan WF; Wertheimer AI; Marttila JK
    Contemp Pharm Pract; 1980; 3(4):203-9. PubMed ID: 10298036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital.
    Bremberg ER; Hising C; Nylén U; Ehrsson H; Eksborg S
    J Oncol Pharm Pract; 2006 Jun; 12(2):75-81. PubMed ID: 16984745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decade of experience with a clinical pharmacokinetics service.
    Ambrose PJ; Smith WE; Palarea ER
    Am J Hosp Pharm; 1988 Sep; 45(9):1879-86. PubMed ID: 3147596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care versus central laboratory testing: an economic analysis in an academic medical center.
    Tsai WW; Nash DB; Seamonds B; Weir GJ
    Clin Ther; 1994; 16(5):898-910; discussion 854. PubMed ID: 7859247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of federal indicators in nursing-home drug-regimen review.
    Shannon RC; De Muth JE
    Am J Hosp Pharm; 1984 May; 41(5):912-6. PubMed ID: 6731451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum drug level utilization: a literature analysis.
    Einarson TR; Segal HJ; Mann JL
    Can J Hosp Pharm; 1989 Apr; 42(2):63-8, 88. PubMed ID: 10318233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical pharmacist in internal medicine--impact on the quality of therapeutic care].
    Hammerman A; Rotem R; Meidan N; Porath A
    Harefuah; 1999 Jun; 136(11):862-4. PubMed ID: 10955131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist impact on drug use in an institution for the mentally retarded.
    Ellenor GL; Frisk PA
    Am J Hosp Pharm; 1977 Jun; 34(6):604-8. PubMed ID: 879182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting appropriate therapy in a long-term care facility.
    Hood JC; Lemberger M; Steward RB
    J Am Health Care Assoc; 1975 Sep; 1(2):10-3. PubMed ID: 10246872
    [No Abstract]   [Full Text] [Related]  

  • 17. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program.
    Carter BL; Chrischilles EA; Scholz D; Hayase N; Bell N
    J Am Pharm Assoc (Wash); 2003; 43(1):24-33. PubMed ID: 12585748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pharmacists' clinical interventions on nonformulary drug use.
    Packer LA; Mahoney CD; Rich DS; Jeffrey LP
    Am J Hosp Pharm; 1986 Jun; 43(6):1461-6. PubMed ID: 3728481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consultant pharmacist impact on antihypertensive therapy in a geriatric long-term care facility.
    Williamson DH; Cooper JW; Kotzan JA; Gelbart AO
    Hosp Formul; 1984 Feb; 19(2):123-8. PubMed ID: 10264741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.